Sanara MedTech Inc.

SMTI Healthcare Medical Instruments & Supplies

Sanara MedTech Inc.’s revenue for fiscal 2025 (year ended December 2025) was $103.1 million, up 19.0% from fiscal 2024. In the quarter to June 2026, revenue grew 9.04%, EPS grew 78.3%, free cash flow grew 131.3% and total debt rose 5.11%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

33.14 1.95 −5.56%
Market cap
$322.4M
P/E
0.0×
Fwd P/E
125×
Dividend yield
—
F-score
4/9
Altman Z
2.35
Beneish M
−3.22
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 4 4 4

+8 more TTM periods

ROE
(147.79%) (153.71%) (167.53%) (164.45%)
ROA
(38.13%) (40.54%) (46.65%) (46.97%)
ROIC
13.49% 14.38% 12.92% 19.20%
Return on Tangible Assets
(159.01%) (186.99%) (244.35%) (262.45%)
Average Days of Receivables
41.79 46.24 42.47 43.30
Free Cash Flow per Share
0.52 0.39 0.25 (0.10)
Free Cash Flow
4.50 3.37 2.17 (0.83)
Other line items

Show all line items

Columns are period end dates